外周动脉疾病当前管理:聚焦药物治疗
该综述总结PAD的临床表现、危险因素和药物治疗,强调早期诊断和二级心血管预防(降脂、降压、抗栓、戒烟、控糖和运动)至关重要,但目前实施不佳。
要点
- PAD患者主要不良心血管事件风险高,早期诊断和二级预防至关重要。
- 药物治疗包括他汀、依折麦布、PCSK9抑制剂降脂,降压药和抗栓药。
- 戒烟、控糖和运动计划同样关键,但当前这些治疗实施不佳。
核心结论
- PAD患者主要不良心血管事件风险高,早期诊断和实施二级心血管预防至关重要。
- 当前降脂、降压、抗栓、戒烟、控糖和运动等治疗实施不佳,需全球努力改善预后。
研究设计与样本
- 综述,总结PAD的临床表现、危险因素和药物治疗管理。
主要发现
- PAD症状异质,需高度怀疑以避免诊断和治疗延迟。
- 传统诊断方法为踝臂压力指数或动脉双功超声。
- PAD患者主要不良心血管事件风险高。
关键数值与推荐
- 降脂治疗包括他汀、依折麦布和PCSK9抑制剂。
- 降压药物和抗血栓药物用于降低心血管风险。
- 戒烟、控糖(如相关)和运动计划同样关键。
临床怎么用
- 对疑似PAD者应测量踝臂压力指数或行动脉双功超声以早期诊断。
- 确诊PAD后应启动二级心血管预防,包括降脂、降压、抗栓、戒烟、控糖和运动。
- 关注当前治疗实施不佳的现状,努力落实最佳实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Peripheral artery disease (PAD) is the occlusion or narrowing of the arteries supplying the lower extremities. Peripheral artery disease has been estimated to affect approximately 240 million people worldwide, approximately 70% of whom are within low- or middle-income countries. Due to the ageing population and diabetes epidemic, the prevalence of PAD is rapidly rising. The symptoms of PAD are heterogeneous and thus a high index of suspicion is needed to prevent delays in diagnosis and treatment. Measurement of ankle brachial pressure index or arterial duplex ultrasound are traditionally used to diagnose PAD. Patients with PAD have a high risk of major adverse cardiovascular events. Early diagnosis and implementation of secondary cardiovascular prevention is therefore critical. This includes therapies to reduce low-density lipoprotein cholesterol, such as statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, blood-pressure reducing medications and anti-thrombotic drugs. Treatments to facilitate smoking cessation and control blood sugar if relevant and an exercise programme are also critical in reducing cardiovascular risk. Currently, these treatments are not well implemented. This review summarises the clinical presentation, risk factors and medical management of PAD. Global efforts are needed to reduce the burden from the growing PAD epidemic by implementing best practices and improving outcomes through further research.
引用
- Golledge J, Fernando ME, Armstrong DG, et al. Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy. Drugs. 2022. PMID: 35960432. doi:10.1007/s40265-022-01755-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。